BioCentury | Feb 12, 2020
Tools & Techniques

NCATS, FDA meeting shines light on AAV manufacturing innovation

...the functions that are required to make AAV are stably integrated into the cell.” Nicole Faust...
...that are required to make AAV are stably integrated into the cell,” said CEO Nicole Faust...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...company and will remain on the board. Renal disease play Tricida Inc. (NASDAQ:TCDA) hired Elizabeth Faust...
BioCentury | Sep 29, 2014
Company News

Cevec management update

...Supply/Service, Biomanufacturing Hired: Frank Ubags as COO, formerly COO of Scil Proteins GmbH Transitioned: Nicole Faust...
BioCentury | Jul 25, 2013
Distillery Techniques

Technology: Drug platforms

...nonhuman primates. SciBX 6(28); doi:10.1038/scibx.2013.740 Published online July 25, 2013 Patent and licensing status unavailable Faust...
BioCentury | Jun 23, 2011
Targets & Mechanisms

Neutralizing lupus autoantibodies

...H. et al. PLoS ONE 3 , e3347; published online Oct. 6, 2008; doi:10.1371/journal.pone.0003347 4. Faust...
BioCentury | Nov 9, 2009
Company News

Domain Therapeutics, Takeda deal

...Domain (formerly Faust Pharmaceuticals S.A. ) received an undisclosed milestone payment from Takeda under a 2008 deal to...
BioCentury | Apr 3, 2008
Targets & Mechanisms

Follow the Follistatin

...the DMD gene DMD Phase I/II Acceleron Pharma Inc. ACE-031 Myostatin (GDF8) inhibitor MD Preclinical Faust Pharmaceuticals S.A....
BioCentury | Mar 20, 2008
Cover Story

The 'Smoking Gun' in ALS

...III CytRx Corp. (NASDAQ:CYTR) Arimoclomol Hydroxylamine derivative that induces heat shock protein expression Phase IIbA Faust Pharmaceuticals S.A....
BioCentury | Mar 12, 2008
Politics & Policy

Researchers issue report on NIH funding

...and Pensions (HELP) Committee hearing on the topic on Wednesday, Harvard University President Drew Gilpin Faust...
BioCentury | Jan 14, 2008
Company News

Faust, Takeda deal

...drug candidates against undisclosed G protein-coupled receptors (GPCRs) for Takeda. Further terms were not disclosed. Faust Pharmaceuticals S.A....
Items per page:
1 - 10 of 30
BioCentury | Feb 12, 2020
Tools & Techniques

NCATS, FDA meeting shines light on AAV manufacturing innovation

...the functions that are required to make AAV are stably integrated into the cell.” Nicole Faust...
...that are required to make AAV are stably integrated into the cell,” said CEO Nicole Faust...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...company and will remain on the board. Renal disease play Tricida Inc. (NASDAQ:TCDA) hired Elizabeth Faust...
BioCentury | Sep 29, 2014
Company News

Cevec management update

...Supply/Service, Biomanufacturing Hired: Frank Ubags as COO, formerly COO of Scil Proteins GmbH Transitioned: Nicole Faust...
BioCentury | Jul 25, 2013
Distillery Techniques

Technology: Drug platforms

...nonhuman primates. SciBX 6(28); doi:10.1038/scibx.2013.740 Published online July 25, 2013 Patent and licensing status unavailable Faust...
BioCentury | Jun 23, 2011
Targets & Mechanisms

Neutralizing lupus autoantibodies

...H. et al. PLoS ONE 3 , e3347; published online Oct. 6, 2008; doi:10.1371/journal.pone.0003347 4. Faust...
BioCentury | Nov 9, 2009
Company News

Domain Therapeutics, Takeda deal

...Domain (formerly Faust Pharmaceuticals S.A. ) received an undisclosed milestone payment from Takeda under a 2008 deal to...
BioCentury | Apr 3, 2008
Targets & Mechanisms

Follow the Follistatin

...the DMD gene DMD Phase I/II Acceleron Pharma Inc. ACE-031 Myostatin (GDF8) inhibitor MD Preclinical Faust Pharmaceuticals S.A....
BioCentury | Mar 20, 2008
Cover Story

The 'Smoking Gun' in ALS

...III CytRx Corp. (NASDAQ:CYTR) Arimoclomol Hydroxylamine derivative that induces heat shock protein expression Phase IIbA Faust Pharmaceuticals S.A....
BioCentury | Mar 12, 2008
Politics & Policy

Researchers issue report on NIH funding

...and Pensions (HELP) Committee hearing on the topic on Wednesday, Harvard University President Drew Gilpin Faust...
BioCentury | Jan 14, 2008
Company News

Faust, Takeda deal

...drug candidates against undisclosed G protein-coupled receptors (GPCRs) for Takeda. Further terms were not disclosed. Faust Pharmaceuticals S.A....
Items per page:
1 - 10 of 30